Medicare Enrolled
Dr. John Visconti, DO
Medical Oncology · Shiloh, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Visconti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Visconti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Visconti
Dr. John Visconti is a medical oncology specialist in Shiloh, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Visconti performed 196,153 Medicare services across 2,831 unique beneficiaries.
Between the years covered by Open Payments, Dr. Visconti received a total of $805 from 13 pharmaceutical and/or device companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Visconti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in IL
$805 industry payments
Medicare Practice Summary
Medicare Utilization ↗196,153
Medicare services
Top 2% in IL for medical oncology
2,831
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,808 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
32,250 | $1 | $4 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
27,650 | $2 | $17 |
| Pembrolizumab injection (Keytruda) | 24,400 | $43 | $117 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
17,450 | $0 | $8 |
| Denosumab injection (Prolia/Xgeva) | 15,720 | $18 | $55 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
13,680 | $38 | $103 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
13,050 | $0 | $5 |
| Paclitaxel chemotherapy injection | 8,718 | $0 | $1 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 6,190 | $38 | $180 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,900 | $0 | $4 |
| Injection, atropine sulfate, 0.01 mg | 5,000 | $0 | $1 |
| Bevacizumab biosimilar injection, 10 mg An injection of bevacizumab-awwb, a biosimilar medication, administered in a 10 mg dose. |
3,886 | $23 | $151 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,970 | $23 | $155 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,320 | $1 | $61 |
| Injection, leucovorin calcium, per 50 mg | 2,062 | $3 | $22 |
| Injection, granisetron hydrochloride, 100 mcg | 1,470 | $0 | $9 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,335 | $2 | $29 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
1,236 | $81 | $1,155 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,213 | $68 | $151 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 1,027 | $3 | $86 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
848 | $97 | $594 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
746 | $11 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
683 | $12 | $142 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
673 | $22 | $203 |
| Injection, potassium chloride, per 2 meq | 560 | $0 | $4 |
| Injection, irinotecan, 20 mg | 549 | $2 | $249 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
320 | $13 | $37 |
| Anti-nausea injection (ondansetron/Zofran) | 304 | $0 | $20 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
295 | $2 | $11 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
280 | $2 | $27 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
263 | $46 | $225 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
234 | $1 | $10 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
220 | $50 | $277 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
174 | $15 | $125 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
169 | $2 | $31 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
159 | $22 | $190 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
151 | $10 | $125 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
151 | $54 | $319 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
134 | $42 | $247 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
129 | $1 | $23 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
126 | $206 | $927 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
123 | $7 | $110 |
| Blood or blood product transfusion The administration of whole blood or specific blood components into a patient's bloodstream. |
120 | $30 | $235 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
112 | $1 | $30 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
110 | $18 | $159 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
105 | $15 | $125 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 104 | $135 | $4,005 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
97 | $24 | $151 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
96 | $130 | $392 |
| Leukocyte-reduced red blood cell unit A unit of red blood cells that has been processed to remove white blood cells (leukocytes) before transfusion. |
93 | $69 | $335 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
82 | $24 | $214 |
| Injection, alteplase recombinant, 1 mg | 65 | $67 | $180 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
58 | $68 | $260 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
41 | $34 | $59 |
| Irradiated red blood cell unit A unit of red blood cells that has been treated to remove white blood cells and irradiated to prevent immune reactions. |
39 | $192 | $403 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
38 | $1 | $20 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $63 | $210 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
33 | $24 | $142 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
31 | $132 | $844 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $28 | $178 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
26 | $78 | $402 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $91 | $236 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.8% high complexity
81.1% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$805
Total received (2018-2024)
Avg $115/year across 7 years
Bottom 41% in IL for medical oncology
13
Companies
28
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$608 (75.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (24.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$112
2023
$276
2022
$195
2021
$11
2020
$31
2019
$17
2018
$164
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$73
Merck Sharp & Dohme LLC
$24
Gilead Sciences, Inc.
$16
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$175
EMD Serono, Inc.
$137
Bayer Healthcare Pharmaceuticals Inc.
$116
Pharmacyclics LLC, An AbbVie Company
$83
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Gilead Sciences, Inc.
$60
Merck Sharp & Dohme LLC
$43
Janssen Biotech, Inc.
$31
Merck Sharp & Dohme Corporation
$29
Genentech USA, Inc.
$20
Taiho Oncology, Inc.
$18
ADC Therapeutics America, Inc.
$11
PFIZER INC.
$11
Top 3 companies account for 53.1% of all-time payments
Associated products mentioned in payments ›
Avastin · BAVENCIO · EPKINLY · Erleada · GILOTRIF · IMBRUVICA · Imbruvica · KEYTRUDA · Lonsurf · Nubeqa · SUTENT · Trodelvy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
64
Per 100K population
25.1
County median income
$70,178
Nearest hospital
HSHS ST ELIZABETH'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Visconti is a mixed practice specialist, with above-average Medicare volume (top 2% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Visconti experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Visconti performed 32,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Visconti receive payments from pharmaceutical companies?
Yes. Dr. Visconti received a total of $805 from 13 companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Visconti's costs compare to other medical oncologists in Shiloh?
Dr. Visconti's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Visconti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Shiloh
Browse medical oncologists in Shiloh ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in IL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in IL
Which IL medical oncologists receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology